logo
The doctor will be arriving ... in a mailbox

The doctor will be arriving ... in a mailbox

The Star16-06-2025
You can now do self-administered tests for everything from thyroid function to Human Immunodeficiency Virus (HIV) in the privacy of your own home – and that list continues to grow, as the United States Food and Drug Administration (FDA) recently approved the first at-home cervical cancer test.
While the tests can make it easier for people to access healthcare and can be helpful for those who have extreme anxiety about sensitive or invasive medical exams, experts warn that most of the tests cannot replace an actual in-person visit.
Here's what doctors say you can test for at home, and when you should make the trek to your physician's office.
There are two kinds at 'at-home tests.'
In one type, the patient collects the sample and sends it off to a lab; the new cervical cancer test is like this.
The other gives an instant result – think Covid-19 and pregnancy tests.
HIV home-testing kits can improve rates of diagnosing sexually transmitted ­infections (STIs) in rural communities and help people who are nervous about going to the doctor to seek a sensitive test, said Dr Joseph Cherabie, an infectious diseases specialist in St. Louis, Missouri.
'You really want to get people to care as quickly as possible, but some people could be very anxious about that results as well,' Dr Cherabie said. 'And they have very negative reactions.'
Labs are required to report a positive HIV test, instead of putting the onus on the patient who took the test, he said, and often, the patient is matched up with HIV support services.
'If you are part of a sexual and gender minority community, going to a doctor's office can be full of a lot of ­historical trauma, and you may prefer to just do testing at home without anyone judging you or asking you invasive questions about your sex life,' Dr Cherabie said.
The new cervical cancer test – which tests for strains of human papillomavirus, or HPV – involves a testing swab that's like a tampon, said Dr Susan Modesitt, a gynaecologic oncologist at Emory University in Atlanta.
It is not, she said, a replacement for a Pap smear, the exam in which a metal speculum is inserted in the vagina to scrape cervix cells.
A doctor's visit also involves a pelvic exam, a chance to talk about abnormal bleeding – a sign of endometrial cancer – and other symptoms and issues, like menopause or STIs.
'There are so many other reasons to see your doctor and get an exam outside of a cervical cancer screening,' Dr Modesitt said.
The at-home cervical cancer test from Teal Health requires a prescription, and the company said that results are not left for the patient to interpret.
Colon cancer screening
Some at-home tests can replace a trip to the doctor's office.
That's especially true in rural areas, where it can be difficult to get a colonoscopy.
'The colonoscopy requires a pre-op, and you have to drive maybe 70 miles (113km) for it,' said Dr Steven Furr, board chair of the American Academy of Family Physicians who practices in rural Alabama.
'You get anaesthesia. It's actually almost like a surgical procedure in many ways.
'So, for a lot of people, that's pretty arduous. That's where an at-home test can come in handy.'
But, Dr Furr said, if your test reveals issues, you need to go to your doctor.
Plus, patients should always discuss test results with their physician instead of interpreting them on their own, he said.
If you have symptoms of what you're testing for, go to the doctor.
At-home colon cancer tests aren't the right option for people with a history of colon cancer or high-risk conditions, such as inflammatory bowel disease, said Dr Zachariah Foda, a ­gastroenterologist at Johns Hopkins.
He added that they're also not recommended for people who are having gastrointestinal symptoms.
While there are tests for many things – running anywhere from $15 (RM64) to $400 (RM1,693), depending on what is being evaluated – Dr Furr said it's essential to make sure that your test is FDA-approved so you can better trust the results.
'Anytime we get people involved in their own healthcare and help them understand what's going on, I think that's a good thing and it gives us a chance to talk,' he said.
'Any kind of screening is better than no screening.' – AP
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Over 9,300 begin PrEP treatment since 2023 as MOH expands HIV/AIDS awareness
Over 9,300 begin PrEP treatment since 2023 as MOH expands HIV/AIDS awareness

New Straits Times

time21 hours ago

  • New Straits Times

Over 9,300 begin PrEP treatment since 2023 as MOH expands HIV/AIDS awareness

KUALA LUMPUR: A total of 9,309 people have started Pre-Exposure Prophylaxis (PrEP) treatment from January 2023 up to June this year. Health Minister Datuk Seri Dr Dzulkefly Ahmad said the ministry aimed to strengthen HIV/AIDS prevention treatment programmes, including through PrEP. "PrEP treatment is provided for spouses of People Living with HIV/AIDS (PLHIV) and at-risk individuals. "PrEP can reduce the risk of acquiring HIV through sexual activity by about 99 per cent when taken as prescribed. "PrEP services have been available in 35 health clinics since January 2023, with 9,309 individuals starting treatment as of June," he said in a written parliamentary reply. He said the government is also expanding coverage of antiretroviral (ARV) treatment among PLHIV and ensuring adherence to prescribed regimens to enable them to live normal lives. In 2024, he said 50,694 PLHIV received ARV treatment, an increase of 3.8 per cent compared with 2023 (48,765 people). Dzulkefly said the ministry is also enhancing HIV/AIDS literacy and awareness among the public, especially youths and adolescents. He said the PROSTAR 2.0 programme is one initiative aimed at improving resilience and awareness among youths regarding HIV and sexually transmitted infections (STIs), emphasising the biopsychosocial-spirituality aspects. "As of June 2025, a total of 592 PROSTAR 2.0 activities involving 55,241 students from schools and higher learning institutions have been carried out, showing a 26 per cent increase in knowledge," he said. The ministry, he said, also launched the HIV Self-Test and TestNow website in December 2023, which provides information on HIV, risk assessments, and access to self-test kits. As of June 2025, the website recorded 188,425 visitors, averaging 324 visitors daily, with 13.4 per cent categorised as high-risk for HIV. He said the ministry is also expanding Differentiated HIV Services for Key Populations under the KK 2.0 Model in 33 health clinics, through smart partnerships between government and NGOs, to improve HIV service delivery particularly to key populations. He was responding to a question from Datuk Ahmad Saad @ Yahaya (PN-Pokok Sena) on the government's actions in addressing the rise of men who have sex with men (MSM), which has been the main driver of HIV infections in the country over the past decade. Dzulkefly said addressing MSM cases requires a holistic collaboration involving multiple parties, including government agencies, the private sector, and corporations.

Vaccine panel conflicts at historic low when Kennedy fired members
Vaccine panel conflicts at historic low when Kennedy fired members

The Sun

time21 hours ago

  • The Sun

Vaccine panel conflicts at historic low when Kennedy fired members

CONFLICTS of interest on the U.S. Centers for Disease Control and Prevention's vaccine advisory committee were at historic lows around the time when Health Secretary Robert F. Kennedy Jr. fired all 17 members in June, new data published in a medical journal on Monday showed. Kennedy had said, based on findings from a 2007 report, that the Advisory Committee on Immunization Practices (ACIP) was rife with conflicts. The new study published in JAMA found that between 2000 and 2024, ACIP's annual reported conflict of interest rate declined from 42.8% to 5%. ACIP advises on which groups of people should take each vaccine approved by the U.S. Food and Drug Administration, and when they should be administered. Conflict of interest rates on the FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC), which advises the agency on whether to approve vaccines, have remained below 4% since 2010, including 10 years when it was 0%, the researchers also found. The most frequently reported conflict of interest was funding for research, which is generally considered less concerning than financial ties associated with personal income, the researchers said. The prevalence of conflicts related to personal income – such as from consulting, royalties, or stock ownership – had been below 1% for both committees since 2016. 'In the past, there have been high levels of reported conflicts on influential vaccine committees, but there has been substantial progress since the early 2000s,' study leader Genevieve Kanter of the Schaeffer Center at the University of Southern California said in a statement. 'Secretary Kennedy is right that conflict of interest is an important issue, but he is wrong that it is present at substantial levels on (U.S. Department of Health and Human Services) vaccine advisory committees,' co-author Peter Lurie, president of the Center for Science in the Public Interest and former FDA associate commissioner, said in a statement. Responding to the study, Department of Health and Human Services press secretary Emily Hilliard said, 'Secretary Kennedy is committed to eliminating both real and perceived conflicts to strengthen confidence in public health decisions.' Earlier this year, the agency launched its ACIP Conflicts of Interest Disclosures tool, she noted. - Reuters

More Malaysians with HIV receive antiretroviral therapy last year, Parliament heard
More Malaysians with HIV receive antiretroviral therapy last year, Parliament heard

The Star

time21 hours ago

  • The Star

More Malaysians with HIV receive antiretroviral therapy last year, Parliament heard

KUALA LUMPUR: More people living with HIV were receiving antiretroviral therapy (ART) in Malaysia last year, the Dewan Rakyat was told. According to the Health Ministry, 50,694 individuals living with HIV have been receiving ART in Malaysia last year, compared to 48,765 individuals in 2023. 'This is an increase of 3.8% compared to 2023,' said the Health Ministry in a parliamentary written reply dated Aug 18. The Health Ministry said that since PrEP (Pre-Exposure Prophylaxis) was introduced in January 2023, it has been offered at 35 public health clinics. Up till June this year, a total of 9,309 individuals have received PrEP, it said. The Health Ministry was responding to Datuk Ahmad Saad (PN-Pokok Sena), who asked about measures to address the rise of HIV in the country.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store